Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Telangiectasis 1Rosacea 1Port-Wine Stain 1Hemangioma 1Breast Neoplasms 1Barrett Esophagus 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Tomography, Optical Coherence × Clear all
NCT04336163 2024-01-30

Skin Imaging to Inform Laser Treatments

University of California, Irvine

Phase NA Terminated
55 enrolled 6 charts

Hemangioma, Rosacea, Telangiectasis, Port-Wine Stain

NCT03434834 2021-04-06

OCT Pilot in Esophagus

Duke University

Phase NA Completed
53 enrolled 9 charts
Gastrointestinal

Barrett Esophagus

NCT01699867 2015-01-06

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part A)

Diagnostic Photonics, Inc.

Completed
50 enrolled 5 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡